These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35114767)

  • 1. Effectiveness, economical and safety aspects of growth hormone (GH) therapy in growth promoting doses in patients with isolated GH deficiency after the attainment of near-final height. Is there a need to modify the criteria of therapy withdrawal?
    Smyczyńska J; Hilczer M; Lewinski A; Smyczyńska U; Stawerska R
    Pediatr Endocrinol Diabetes Metab; 2021; 27(4):258-265. PubMed ID: 35114767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.
    Zucchini S; Pirazzoli P; Baronio F; Gennari M; Bal MO; Balsamo A; Gualandi S; Cicognani A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary IGF-I deficiency as a prognostic factor of growth hormone (GH) therapy effectiveness in children with isolated, non-acquired GH deficiency.
    Smyczyńska J; Stawerska R; Hilczer M; Lewiński A
    Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):209-14. PubMed ID: 25607339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and predictors of persistent growth hormone deficiency (GHD) in patients with isolated, childhood-onset GHD.
    Smyczyńska J; Stawerska R; Lewiński A; Hilczer M
    Endokrynol Pol; 2014; 65(5):334-41. PubMed ID: 25301482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Growth Hormone Deficiency (GHD) Reversal Trial: effect on final height of discontinuation versus continuation of growth hormone treatment in pubertal children with isolated GHD-a non-inferiority Randomised Controlled Trial (RCT).
    Brettell E; Högler W; Woolley R; Cummins C; Mathers J; Oppong R; Roy L; Khan A; Hunt C; Dattani M;
    Trials; 2023 Aug; 24(1):548. PubMed ID: 37605233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient Isolated, Idiopathic Growth Hormone Deficiency-A Self-Limiting Pediatric Disease with Male Predominance or a Diagnosis Based on Uncertain Criteria? Lesson from 20 Years' Real-World Experience with Retesting at One Center.
    Smyczyńska J; Hilczer M; Smyczyńska U; Lewiński A; Stawerska R
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of growth hormone therapy on Taiwanese children with growth hormone deficiency.
    Huang YH; Wai YY; Van YH; Lo FS
    J Formos Med Assoc; 2012 Jul; 111(7):355-63. PubMed ID: 22817812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to growth hormone treatment in isolated growth hormone deficiency versus multiple pituitary hormone deficiency.
    Darendeliler F; Lindberg A; Wilton P
    Horm Res Paediatr; 2011; 76 Suppl 1():42-6. PubMed ID: 21778748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reassessment of growth hormone status is required at final height in children treated with growth hormone replacement after radiation therapy.
    Gleeson HK; Gattamaneni HR; Smethurst L; Brennan BM; Shalet SM
    J Clin Endocrinol Metab; 2004 Feb; 89(2):662-6. PubMed ID: 14764778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth response, pubertal growth and final height in Greek children with growth hormone (GH) deficiency on long-term GH therapy and factors affecting outcome.
    Karavanaki K; Kontaxaki C; Maniati-Christidi M; Petrou V; Dacou-Voutetakis C
    J Pediatr Endocrinol Metab; 2001 Apr; 14(4):397-405. PubMed ID: 11327373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth Hormone (GH) Therapy During the Transition Period: Should We Think About Early Retesting in Patients with Idiopathic and Isolated GH Deficiency?
    Penta L; Cofini M; Lucchetti L; Zenzeri L; Leonardi A; Lanciotti L; Galeazzi D; Verrotti A; Esposito S
    Int J Environ Res Public Health; 2019 Jan; 16(3):. PubMed ID: 30678118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do all patients with childhood-onset growth hormone deficiency (GHD) and ectopic neurohypophysis have persistent GHD in adulthood?
    Léger J; Danner S; Simon D; Garel C; Czernichow P
    J Clin Endocrinol Metab; 2005 Feb; 90(2):650-6. PubMed ID: 15546901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth Responses During 3 Years of Growth Hormone Treatment in Children and Adolescents With Growth Hormone Deficiency: Comparison Between Idiopathic, Organic and Isolated Growth Hormone Deficiency, and Multiple Pituitary Hormone Deficiency.
    Lim HH; Kim YM; Lee GM; Yu J; Han HS; Yu J
    J Korean Med Sci; 2022 Mar; 37(11):e90. PubMed ID: 35315601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is retesting in growth hormone deficient children really useful?
    Meazza C; Gertosio C; Pagani S; Pilotta A; Tinelli C; Buzi F; Farello G; Genoni G; Bona G; Bozzola M
    Minerva Endocrinol; 2017 Dec; 42(4):325-330. PubMed ID: 27304071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults.
    Maghnie M; Strigazzi C; Tinelli C; Autelli M; Cisternino M; Loche S; Severi F
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1324-8. PubMed ID: 10199773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of permanent growth hormone deficiency (GHD) in young adults with childhood onset GHD: a multicenter study.
    Berberoğlu M; Sıklar Z; Darendeliler F; Poyrazoğlu S; Darcan S; Işgüven P; Bideci A; Ocal G; Bundak R; Yüksel B; Arslanoğlu I
    J Clin Res Pediatr Endocrinol; 2008; 1(1):30-7. PubMed ID: 21318062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone (GH) secretion in patients with childhood-onset GH deficiency: retesting after one year of therapy and at final height.
    Thomas M; Massa G; Maes M; Beckers D; Craen M; François I; Heinrichs C; Bourguignon JP;
    Horm Res; 2003; 59(1):7-15. PubMed ID: 12566729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study.
    Cappa M; Iughetti L; Loche S; Maghnie M; Vottero A;
    J Endocrinol Invest; 2016 Jun; 39(6):667-77. PubMed ID: 27223400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation.
    Takeda A; Cooper K; Bird A; Baxter L; Frampton GK; Gospodarevskaya E; Welch K; Bryant J
    Health Technol Assess; 2010 Sep; 14(42):1-209, iii-iv. PubMed ID: 20849734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.